Immuron IMRN
NASDAQ IMRN
$0.95 -0.02 (-2.13%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Non Operating Interest Expenses (2023 - 2024)

Updated

Immuron (IMRN) recorded Non Operating Interest Expenses of -$14,712 in FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Non Operating Interest Expenses (2023 - 2024) Analysis & Trends

Starting with FY2015, Immuron's Non Operating Interest Expenses history includes 12 fiscal years.

  • The FY2026 figure is the lowest annual Non Operating Interest Expenses since FY2020.
  • Per Business Quant data, IMRN's Non Operating Interest Expenses was -$7,305 in FY2025, -$75.76 in FY2024, $4,007 in FY2023 (-11.0%) and $4,501 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Immuron 7.02 Mn -10.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4,954.38
Sep 9, 2024 -50.48
Dec 31, 2023 -62.83
API Access

Immuron Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IMRN&period=max&api_key=YOUR_API_KEY